RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2010; 104(04): 858-859
DOI: 10.1160/TH10-01-0041
DOI: 10.1160/TH10-01-0041
Letters to the Editor
Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia
Autoren
Weitere Informationen
Publikationsverlauf
Received:
14. Januar 2010
Accepted after minor revision:
11. Juni 2010
Publikationsdatum:
24. November 2017 (online)
-
References
- 1 Althaus K, Greinacher A. MYH9-related platelet disorders.. Semin Thromb Haemost 2009; 35: 189-203.
- 2 Savoia A, De Rocco D, Panza E. et al. Heavy chain myosin 9-related disease (MYH9 -RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder.. Thromb Haemost 2010; 103: 826-832.
- 3 Pecci A, Panza E, Pujol-Moix N. et al. Position of Nonmuscle Myosin Heavy Chain IIA (NMMHCIIA) mutations predicts the natural history of MYH9-related disease.. Hum Mutat 2008; 29: 409-417.
- 4 Nurden P, Nurden AT. Congenital disorders associated with platelet disfunction.. Thromb Haemost 2008; 99: 253-263.
- 5 Girolami A, Randi M, Casonato A. et al. A study of platelet function and morphology in a new family with May-Hegglin anomaly.. Folia Haematol Int Mag Klin Morphol Blutforsch 1980; 107: 256-268.
- 6 Pecci A, Malara A, Badalucco S. et al. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.. Thromb Haemost 2009; 102: 90-96.
- 7 Speletas M, Katodritou E, Daiou C. et al. Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders.. Leuk Res 2007; 31: 1053-1062.
- 8 Dentali F, Squizzato A, Brivio L. et al. JAKV617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.. Blood 2009; 113: 5617-5623.
- 9 Lussana F, Caberlon S, Pagani C. et al. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.. Thromb Res 2009; 124: 409-417.
- 10 McDunn S, Hartz W, Ts’ao C, Green D. Coronary thrombosis in a patient with May-Hegglin anomaly.. Am J Clin Pathol 1991; 95: 715-718.
- 11 Goto S, Hasahara H, Sakai H. et al. Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute infarction.. Int J Cardiol 1998; 64: 171-177.
- 12 Everlien M, Knoch K, Farah I, Greve H. Koronare bypassoperation bei May-Hegglin-Anomalie (Coronary bypass surgery in May-Hegglin anomaly).. Dtsch Med Wochenschr 2001; 126: 47-49.
- 13 Varbella F, Bongioanni S, Gagnor A. et al. (Primary angioplasty in a patient with the May-Hegglin anomaly, a rare hereditary thrombocytopenia.. A case report and review of the literature.) Ital Heart J Suppl 2005; 6: 214-217.
- 14 Heller PG, Pecci A, Glembotsky AC. et al. Unexplained recurrent venous thrombosis in a patient with MYH9-related disease.. Platelets 2006; 17: 274-275.
- 15 Nishiyama Y, Akaishi J, Katsumata T. et al. Cerebral infarction in a patient with macrothrombocytopenia with leucocyte inclusions.. J Nippon Med Sch 2008; 75: 228-232.